BUSINESSCNBC TOP
Healthy Returns: Eli Lilly makes a new push into vaccines – here’s what to know
Eli Lilly announced it will acquire three privately held vaccine makers in deals totaling nearly $4 billion, signaling a significant expansion into the vaccine sector.
Related Signal
Adjacent reporting
- STAT+: Eli Lilly to buy three small vaccine developers
- Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
- STAT+: Pharmalittle: We’re reading about a Lilly gene therapy for cholesterol, three new Lilly deals, and more
- STAT+: Bristol Myers Squibb partners with China’s Hengrui Pharma on a dozen drugs
- UCB to acquire maker of antibody treatments for autoimmune diseases
- Why Brazil’s government is obsessed with vaccines